Abstract.
From 1980 through 1992, 14 children with Henoch-Schönlein nephritis (HSN) showing severe glomerular changes (grade IV or V) were given a multiple combined therapy with prednisolone, cyclophosphamide, heparin/warfarin, and dipyridamole, and were followed for 7.5±0.9 years. The period between the onset of nephritis and the start of therapy was 0.8±0.4 years. Ten patients underwent follow-up biopsy after therapy. The percentage of glomeruli having crescents/segmental lesions was significantly reduced after therapy (70%±5% vs. 42%±7%, P <0.01), due mainly to the resolution of crescents (51%±8% vs. 13%±5%, P <0.01). Thus, histological grade was significantly improved (5 grade IV and 5 grade V vs. 7 grade III and 3 grade IV, P <0.01). After an average follow-up period of 7.5 years, 9 patients showed normal urine and renal function, 4 showed minor urinary abnormalities, and 1 heavy proteinuria. No patient developed chronic renal insufficiency. These findings suggest that the multiple combined therapy could be effective for histologically severe HSN, although a prospective controlled study should be performed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received July 2, 1997; received in revised form September 26, 1997; accepted October 2, 1997
Rights and permissions
About this article
Cite this article
Iijima, K., Ito-Kariya, S., Nakamura, H. et al. Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12, 244–248 (1998). https://doi.org/10.1007/s004670050447
Issue Date:
DOI: https://doi.org/10.1007/s004670050447